IOSP Stock Analysis: Innospec | NASDAQ

Specialty Chemicals | NASDAQ, USA | Market Cap: 1.949m USD | 12M Return: 9.6% | US45768S1050 | Charts, Fundamentals & Technical Analysis

Fuel Additives, Personal Care, Oilfield Services, Mining Reagents
Total Rating 42
Safety 80
Buy Signal -0.63
Specialty Chemicals
Sub-Industry Rotation: -2.9
Market Cap: 1.95B
Avg Turnover: 20.4M
Risk 3d forecast
Volatility27.7%
VaR 5th Pctl4.52%
VaR vs Median-0.78%
Reward TTM
Sharpe Ratio0.33
Rel. Str. IBD35.1
Rel. Str. Peer Group32.1 pctl
Character TTM
Beta0.617
Beta Downside0.693
Hurst Exponent0.526
Choppyness12.2%
Drawdowns 3y
Max DD48.42%
CAGR/Max DD-0.19
CAGR/Mean DD-0.38
EPS (Earnings per Share) EPS (Earnings per Share) of IOSP over the last years for every Quarter: "2021-09": 1.15, "2021-12": 1.3, "2022-03": 1.53, "2022-06": 1.58, "2022-09": 1.74, "2022-12": 1.2, "2023-03": 1.38, "2023-06": 1.28, "2023-09": 1.59, "2023-12": 1.84, "2024-03": 1.75, "2024-06": 1.39, "2024-09": 1.35, "2024-12": 1.41, "2025-03": 1.42, "2025-06": 1.26, "2025-09": 1.12, "2025-12": 1.5, "2026-03": 1.05, "2026-06": 1.27, "2026-09": 1.29,
EPS CAGR: -10.13%
EPS Trend: -92.2%
Last SUE: 0.30
Qual. Beats: 0
Revenue Revenue of IOSP over the last years for every Quarter: 2021-09: 376.1, 2021-12: 413.2, 2022-03: 472.4, 2022-06: 467.6, 2022-09: 513, 2022-12: 510.7, 2023-03: 509.6, 2023-06: 480.4, 2023-09: 464.1, 2023-12: 494.7, 2024-03: 500.2, 2024-06: 435, 2024-09: 443.4, 2024-12: 466.8, 2025-03: 440.8, 2025-06: 439.7, 2025-09: 441.9, 2025-12: 455.6, 2026-03: 453.2, 2026-06: 491.4, 2026-09: 473.6,
Rev. CAGR: -2.27%
Rev. Trend: -63.1%
Last SUE: -0.30
Qual. Beats: 0

Warnings

Below Avwap Earnings
Below Sma 200d

Tailwinds

Seasonal Tailwind

Seasonality 11.9 years of data, until 10/2026

Jan -0.0% 0
Feb -3.7% 14
Mar -1.6% 28
Apr +0.5% 4
May +2.6% 14
Jun -0.3% 0
Jul +0.9% 0
Aug -1.1% 0
Sep -3.7% 28
Oct +0.2% 4
Nov ★ +7.2% 64
Dec +1.7% 0

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.

Description: IOSP Innospec

Innospec Inc. (IOSP) is a U.S.-based specialty chemicals manufacturer headquartered in Englewood, Colorado, founded in 1938 and formerly known as Octel Corp. until its 2006 renaming. The company operates globally across the Americas, Europe, the Middle East, Africa, and Asia-Pacific through three reporting segments: Performance Chemicals, Fuel Specialties, and Oilfield Services.

Its product portfolio centers on chemical additives and formulated solutions rather than bulk commodity chemicals. The Fuel Specialties segment supplies additives for diesel, jet, marine, fuel oil, and other fuels used in commercial trucking, aviation, marine engines, power generation, and industrial machinery, with demand largely driven by emissions and fuel-quality regulations such as ultra-low-sulfur diesel standards and IMO marine fuel rules.

The Performance Chemicals segment delivers technology-based solutions into personal care, home care, agrochemical, construction, and mining markets, while Oilfield Services provides chemistries for drilling, completion, production, and drag-reducing applications in oil and gas. Innospecs customer base spans large multinational industrial firms, fuel marketers and retailers, oilfield service companies, and exploration and production operators.

Headlines to Watch Out For
  • IMO sulfur regulations boost Fuel Specialties additive demand
  • Oilfield Services revenue swings with crude prices and rig counts
  • Performance Chemicals margins hinge on raw material costs
Piotroski VR-10 (Strict) 4.5
Net Income: 140.4m TTM > 0 and > 6% of Revenue
FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.33 > 1.0
NWC/Revenue: 36.46% < 20% (prev 35.36%; Δ 1.10% < -1%)
CFO/TA 0.06 > 3% & CFO 103.6m > Net Income 140.4m
Net Debt (-204.6m) to EBITDA (209.6m): -0.98 < 3
Current Ratio: 2.95 > 1.5 & < 3
Outstanding Shares: last quarter (24.7m) vs 12m ago -0.67% < -2%
Gross Margin: 27.66% > 18% (prev 28.01%; Δ -0.35% > 0.5%)
Asset Turnover: 102.5% > 50% (prev 99.43%; Δ 3.07% > 0%)
Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM)
Altman Z'' 8.12
A: 0.37 (Total Current Assets 1.03b - Total Current Liabilities 351.2m) / Total Assets 1.86b
B: 0.63 (Retained Earnings 1.17b / Total Assets 1.86b)
C: 0.09 (EBIT TTM 170.6m / Avg Total Assets 1.83b)
D: 2.88 (Book Value of Equity 1.37b / Total Liabilities 476.3m)
Altman-Z'' = 8.12 = AAA
Beneish M -2.94
DSRI: 1.08 (Receivables 395.6m/349.5m, Revenue 1.87b/1.79b)
GMI: 1.01 (GM 28.01% / 27.66%)
AQI: 0.95 (AQ_t 0.26 / AQ_t-1 0.27)
SGI: 1.05 (Revenue 1.87b / 1.79b)
TATA: 0.02 (NI 140.4m - CFO 103.6m) / TA 1.86b)
Beneish M = -2.94 (Cap -4..+1) = A
What is the price of IOSP shares?

As of November 22, 2026, the stock is trading at USD 75.56 with a total of 267,178 shares traded. Over the past week, the price has changed by -4.88%, over one month by -22.88%, over three months by -17.71% and over the past year by +9.56%.

Current recommended Stop Loss: 72.00 (which is 4.7% or 1.4 ATR below the current price).

Is IOSP a buy, sell or hold?

Innospec has received a consensus analysts rating of 4.67. Therefore, it is recommended to buy IOSP.

  • StrongBuy: 2
  • Buy: 1
  • Hold: 0
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the IOSP price?
Analysts Target Price 99.3 31.5%
Innospec (IOSP) - Fundamental Data Overview as of 22 November 2026
Market Cap USD = 1.95b (1.95b USD * 1.0 USD.USD)
P/E Trailing = 13.8304
P/E Forward = 12.2549
P/S = 1.0399
P/B = 1.405
P/EG = 0.6612
Revenue TTM = 1.87b USD
EBIT TTM = 170.6m USD
EBITDA TTM = 209.6m USD
Long Term Debt = 33.8m USD (estimated: total debt 47.3m - short term 13.5m)
Short Term Debt = 13.5m USD (from shortTermDebt, last quarter)
Debt = 47.3m USD (from shortLongTermDebtTotal, last quarter) (leases 47.3m already included)
Net Debt = -204.6m USD (calculated: Debt 47.3m - CCE 251.9m)
Enterprise Value = 1.74b USD (1.95b + Debt 47.3m - CCE 251.9m)
 Interest Coverage Ratio = unknown (Ebit TTM 170.6m / Interest Expense TTM 0.0)
 EV/FCF = 42.02x (Enterprise Value 1.74b / FCF TTM 41.5m)
FCF Yield = 2.38% (FCF TTM 41.5m / Enterprise Value 1.74b)
FCF Margin = 2.21% (FCF TTM 41.5m / Revenue TTM 1.87b)
Net Margin = 7.49% (Net Income TTM 140.4m / Revenue TTM 1.87b)
Gross Margin = 27.66% ((Revenue TTM 1.87b - Cost of Revenue TTM 1.36b) / Revenue TTM)
Gross Margin QoQ = 27.26% (prev 28.14%)
Tobins Q-Ratio = 0.94 (Enterprise Value 1.74b / Total Assets 1.86b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 47.3m)
Taxrate = 19.15% (33.4m / 174.4m)
NOPAT = 137.9m (EBIT 170.6m * (1 - 19.15%))
Current Ratio = 2.95 (Total Current Assets 1.03b / Total Current Liabilities 351.2m)
Debt / Equity = 0.03 (Debt 47.3m / totalStockholderEquity, last quarter 1.37b)
Debt / EBITDA = -0.98 (Net Debt -204.6m / EBITDA 209.6m)
Debt / FCF = -4.93 (Net Debt -204.6m / FCF TTM 41.5m)
Total Stockholder Equity = 1.35b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.68% (Net Income 140.4m / Total Assets 1.86b)
RoE = 10.42% (Net Income TTM 140.4m / Total Stockholder Equity 1.35b)
RoCE = 12.36% (EBIT 170.6m / Capital Employed (Equity 1.35b + L.T.Debt 33.8m))
RoIC = 9.68% (NOPAT 137.9m / Invested Capital 1.43b)
WACC = 7.54% (E(1.95b)/V(2.00b) * Re(7.72%) + D(47.3m)/V(2.00b) * Rd(0.0%) * (1-Tc(0.19)))
Discount Rate = 7.72% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -94.27 | Cagr: -0.63%
[DCF] Terminal Value 73.96% ; FCFF base≈43.3m ; Y1≈39.9m ; Y5≈35.4m
[DCF] Fair Price = 31.13 (EV 562.3m - Net Debt -204.6m = Equity 766.9m / Shares 24.6m; r=8.35% [WACC [floored]]; 5y FCF grow -9.98% → 2.50% )
EPS Correlation: -92.24 | EPS CAGR: -10.13% | SUE: 0.30 | # QB: 0
Revenue Correlation: -63.10 | Revenue CAGR: -2.27% | SUE: -0.30 | # QB: 0
EPS current Quarter (2027-03-31): EPS=1.40 | Chg30d=-6.98% | Revisions=-25% | Analysts=2
EPS current Year (2026-12-31): EPS=5.04 | Chg30d=+2.16% | Revisions=-25% | GrowthEPS=-4.3% | GrowthRev=+7.7%
EPS next Year (2027-12-31): EPS=5.97 | Chg30d=-2.93% | Revisions=+25% | GrowthEPS=+18.4% | GrowthRev=+5.7%
[Analyst] Revisions Ratio: -17% (up=1, down=2)